GE Healthcare Bio-Sciences AB is an American multinational conglomerate incorporated in New York and headquartered in Chicago, Illinois. As of 2017, the company is a manufacturer and distributor of diagnostic imaging agents and radiopharmaceuticals for imaging modalities that are used in medical imaging procedures.
In India the Pharmaceutical business of GE Healthcare Bio-Sciences AB is focused on Shielding device, Synthesizer diagnostic cassette simulator, Chromatography column, Determination of chromatography conditions.
GE Healthcare Bio-Sciences AB filed patent application numbered 8188/DELNP/2013 that is titled as SEPARATION METHOD USING SINGLE POLYMER PHASE SYSTEMS. This patent application has been granted as Patent Number 316557.
The invention covers Chemical compound. The invention relates to a process for enriching a target compound from a liquid, which process comprises at least one step of isolation performed by differentially partitioning between two aqueous phases. Thermally responsive, self-associating (ie, clouding) hydrophilic polymer, and if needed some additional salts, to an aqueous biotechnical solution (such as a fermentation sample or bioseparation process stream) Other conditions where the solution separates into a polymer, two-phase system with one phase enriched in the polymer. The target compound is in the process of being enriched in the polymer, while a significant but variable percentage of contaminants may be differentially partitioned to the phase interface or the enriched phase polymer.
During patent examination, the patent examiner raised objections under Section 3(d) of the Indian Patents Act that the claims 1 to 30 appear to be a mere use of a known process which neither results in a new product nor employs any new reactant.
As a response to the said objection, the applicant submits that the present invention provides a novel and inventive method of separation of isolating a target molecule (antibody) from an unclarified CHO broth by mixing a liquid mixture under certain conditions to form a one-polymer, two phase system where the target molecule partitions into the phase not enriched in the polymer at a specific concentration of salts.
Advocate Rahul Dev is a Patent Attorney & International Business Lawyer practicing Technology, Intellectual Property & Corporate Laws. He is reachable at rd (at) patentbusinesslawyer (dot) com & @rdpatentlawyer on Twitter.
Quoted in and contributed to 50+ national & international publications (Bloomberg, FirstPost, SwissInfo, Outlook Money, Yahoo News, Times of India, Economic Times, Business Standard, Quartz, Global Legal Post, International Bar Association, LawAsia, BioSpectrum Asia, Digital News Asia, e27, Leaders Speak, Entrepreneur India, VCCircle, AutoTech).
Regularly invited to speak at international & national platforms (conferences, TV channels, seminars, corporate trainings, government workshops) on technology, patents, business strategy, legal developments, leadership & management.
